Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Alderman B, Hui D, Mukhopadhyay S, Bouleuc C, Case AA, Amano K, Crawford GB, de Feo G, Sbrana A, Tanco K, To J, Garsed J, Davis M. Alderman B, et al. Among authors: bouleuc c. Support Care Cancer. 2022 Dec 16;31(1):39. doi: 10.1007/s00520-022-07480-x. Support Care Cancer. 2022. PMID: 36525085 Review.
[Adapting to the SARS-CoV2 pandemic: Experience of the Curie Institute].
Lucchi-Angellier E, Mino JC, Burnod A, Cottu P, Bozec L, Escalup L, Massing L, Papon M, Rizand P, Fumoleau P, Bouleuc C. Lucchi-Angellier E, et al. Among authors: bouleuc c. Bull Cancer. 2021 Sep;108(9):787-797. doi: 10.1016/j.bulcan.2021.06.001. Epub 2021 Jun 26. Bull Cancer. 2021. PMID: 34334191 Free PMC article. French.
[End of life in pediatric oncology: Is it time to open the debate?].
Orbach D, Serinet MO, Burnod A, Bouleuc C. Orbach D, et al. Among authors: bouleuc c. Bull Cancer. 2023 Jan;110(1):16-18. doi: 10.1016/j.bulcan.2022.11.002. Epub 2022 Nov 22. Bull Cancer. 2023. PMID: 36428109 French. No abstract available.
[A 2022 inventory in oncology news].
Bay JO, Bouleuc C, Caux C, Delom F, Firmin N, Gandemer V, L'Allemain G, Magné N, Orbach D, Robert J, Rodrigues M, Sabatier R, Thiery-Vuillemin A, Wislez M; Comité de rédaction du Bulletin du Cancer. Bay JO, et al. Among authors: bouleuc c. Bull Cancer. 2023 Jan;110(1):19-31. doi: 10.1016/j.bulcan.2022.12.002. Epub 2022 Dec 16. Bull Cancer. 2023. PMID: 36529541 Review. French.
Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
Frasca M, Sabathe C, Delaloge S, Galvin A, Patsouris A, Levy C, Mouret-Reynier MA, Desmoulins I, Vanlemmens L, Bachelot T, Goncalves A, Perotin V, Uwer L, Frenel JS, Ferrero JM, Bouleuc C, Eymard JC, Dieras V, Leheurteur M, Petit T, Dalenc F, Jaffre A, Chevrot M, Courtinard C, Mathoulin-Pelissier S. Frasca M, et al. Among authors: bouleuc c. Eur J Cancer. 2020 Sep;137:240-249. doi: 10.1016/j.ejca.2020.07.007. Epub 2020 Aug 14. Eur J Cancer. 2020. PMID: 32805641
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/guidance on the use of clinically assisted nutrition in patients with advanced cancer.
Alderman B, Allan L, Amano K, Bouleuc C, Davis M, Lister-Flynn S, Mukhopadhyay S, Davies A. Alderman B, et al. Among authors: bouleuc c. Support Care Cancer. 2022 Apr;30(4):2983-2992. doi: 10.1007/s00520-021-06613-y. Epub 2021 Oct 19. Support Care Cancer. 2022. PMID: 34665311 Free PMC article.
Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS.
Chvetzoff G, Bouleuc C, Lardy-Cléaud A, Saltel P, Dieras V, Morelle M, Guastalla JP, Tredan O, Rebattu P, Pop S, Ray-Coquard I, Pierga JY, Mignot L, Laurence V, Bourne-Branchu V, Pérol D, Bachelot T. Chvetzoff G, et al. Among authors: bouleuc c. Support Care Cancer. 2022 Dec 27;31(1):82. doi: 10.1007/s00520-022-07561-x. Support Care Cancer. 2022. PMID: 36574052 Clinical Trial.
Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma.
Lotz JP, Bouleuc C, André T, Touboul E, Macovei C, Hannoun L, Lefranc JP, Houry S, Uzan S, Izrael V. Lotz JP, et al. Among authors: bouleuc c. Cancer. 1996 Jun 15;77(12):2550-9. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2550::AID-CNCR19>3.0.CO;2-R. Cancer. 1996. PMID: 8640705 Clinical Trial.
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Lotz JP, André T, Donsimoni R, Firmin C, Bouleuc C, Bonnak H, Merad Z, Esteso A, Gerota J, Izrael V. Lotz JP, et al. Among authors: bouleuc c. Cancer. 1995 Feb 1;75(3):874-85. doi: 10.1002/1097-0142(19950201)75:3<874::aid-cncr2820750320>3.0.co;2-q. Cancer. 1995. PMID: 7828139 Clinical Trial.
68 results